Aligos Therapeutics, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| NELSON, VAN DENBURG & CAMPBELL WEALTH MANAGEMENT GROUP, LLC | 01/17/2025 | 80 | $3,187 | 100.00% | 0.00% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Aligos Therapeutics, Inc. institutional Ownership - FAQ's
During the previous two years, 10 institutional investors and hedge funds held shares of Aligos Therapeutics, Inc.. The most heavily invested institutionals were:
Nelson, Van Denburg & Campbell Wealth Management Group, LLC: 80
BANK OF AMERICA CORP /DE/: 0
MORGAN STANLEY: 0
NORTHERN TRUST CORP: 0
CITADEL ADVISORS LLC: 0
BlackRock Inc.: 227,406
0.00% of Aligos Therapeutics, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 3.27 M shares in the last 24 months. This purchase volume represents approximately $149.11 M in transactions.